NO20023190L - Orale mukosale doseringsformer for apomorfin - Google Patents

Orale mukosale doseringsformer for apomorfin

Info

Publication number: NO20023190L
Authority: NO; Norway
Prior art keywords: apomorphine; dosage forms; oral mucosal; mucosal dosage; oral
Prior art date: 1999-12-30

Application number

NO20023190A

Other languages

English (en)

Other versions

NO20023190D0 (no

Inventor

Paul Edward Stach

Craig William Davis

Raymundo Acurantes Sison

Robert Kenneth Mansfield

John Daniel Bollinger

Pramod Kumar Gupta

Original Assignee

Tap Holdings Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-30

Filing date

2002-07-01

Publication date

2002-08-29

2002-07-01 Application filed by Tap Holdings Inc filed Critical Tap Holdings Inc

2002-07-01 Publication of NO20023190D0 publication Critical patent/NO20023190D0/no

2002-08-29 Publication of NO20023190L publication Critical patent/NO20023190L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Psychology (AREA)
Zoology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Other In-Based Heterocyclic Compounds (AREA)

NO20023190A 1999-12-30 2002-07-01 Orale mukosale doseringsformer for apomorfin NO20023190L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US47584499A	1999-12-30	1999-12-30
PCT/US2000/034548 WO2001049292A1 (en)	1999-12-30	2000-12-19	Oral mucosal dosage forms of apomorphine

Publications (2)

Publication Number	Publication Date
NO20023190D0 NO20023190D0 (no)	2002-07-01
NO20023190L true NO20023190L (no)	2002-08-29

Family

ID=23889387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023190A NO20023190L (no)	1999-12-30	2002-07-01	Orale mukosale doseringsformer for apomorfin

Country Status (14)

Country	Link
EP (1)	EP1242088A1 (no)
JP (1)	JP2004501065A (no)
CN (1)	CN1414853A (no)
AU (1)	AU2440901A (no)
BR (1)	BR0012822A (no)
CA (1)	CA2394297A1 (no)
CZ (1)	CZ20022245A3 (no)
HK (1)	HK1051315A1 (no)
HU (1)	HUP0400495A3 (no)
IL (1)	IL150034A0 (no)
MX (1)	MXPA02006034A (no)
NO (1)	NO20023190L (no)
PL (1)	PL366204A1 (no)
WO (1)	WO2001049292A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0202365D0 (sv)	2002-08-05	2002-08-05	Pharmacia Ab	New formulation and use thereof
SE0302947D0 (sv)	2003-01-24	2003-11-07	Magle Ab	A composition material for transmucosal delivery
EA012306B1 (ru) *	2003-01-24	2009-08-28	Магле Холдинг Аб	Композиционный материал для доставки через слизистые оболочки
CA2562391A1 (en) *	2004-04-14	2005-10-27	Takeda Pharmaceutical Company Limited	Solid pharmaceutical preparation
GB0509317D0 (en) *	2005-05-06	2005-06-15	Clarke Anthony	Pharmaceutical formulation of apomorphine
FI2442650T4 (fi) *	2009-06-12	2025-08-06	Sunovion Pharmaceuticals Inc	Kielen alle annettava apomorfiini
US20220249465A1 (en) *	2019-05-31	2022-08-11	Primo Pharmatech Llc	Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0865789T3 (da) *	1993-03-26	2005-07-18	Franciscus Wilhelmus He Merkus	Farmaceutiske præparater til intranasal administration af dihydroergotamin
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions

2000
- 2000-12-19 MX MXPA02006034A patent/MXPA02006034A/es unknown
- 2000-12-19 EP EP00988174A patent/EP1242088A1/en not_active Withdrawn
- 2000-12-19 WO PCT/US2000/034548 patent/WO2001049292A1/en not_active Ceased
- 2000-12-19 BR BR0012822-8A patent/BR0012822A/pt not_active IP Right Cessation
- 2000-12-19 CA CA002394297A patent/CA2394297A1/en not_active Abandoned
- 2000-12-19 IL IL15003400A patent/IL150034A0/xx unknown
- 2000-12-19 PL PL00366204A patent/PL366204A1/xx not_active Application Discontinuation
- 2000-12-19 CZ CZ20022245A patent/CZ20022245A3/cs unknown
- 2000-12-19 CN CN00818098A patent/CN1414853A/zh active Pending
- 2000-12-19 HU HU0400495A patent/HUP0400495A3/hu unknown
- 2000-12-19 JP JP2001549660A patent/JP2004501065A/ja not_active Withdrawn
- 2000-12-19 HK HK03101912.0A patent/HK1051315A1/zh unknown
- 2000-12-19 AU AU24409/01A patent/AU2440901A/en not_active Abandoned
2002
- 2002-07-01 NO NO20023190A patent/NO20023190L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2440901A (en)	2001-07-16
MXPA02006034A (es)	2004-08-23
EP1242088A1 (en)	2002-09-25
JP2004501065A (ja)	2004-01-15
CA2394297A1 (en)	2001-07-12
NO20023190D0 (no)	2002-07-01
CZ20022245A3 (cs)	2002-10-16
WO2001049292A1 (en)	2001-07-12
IL150034A0 (en)	2002-12-01
HUP0400495A3 (en)	2007-05-02
PL366204A1 (en)	2005-01-24
BR0012822A (pt)	2004-03-09
CN1414853A (zh)	2003-04-30
HK1051315A1 (zh)	2003-08-01
HUP0400495A2 (hu)	2004-06-28

Publication	Publication Date	Title
NL300328I2 (nl)	2008-07-01	Samenstelling orale dosering met verlengde afgifte
ATE392890T1 (de)	2008-05-15	Hydrogel-gesteuerte dosierungsform
EP1196147A4 (en)	2005-04-20	BUILDING COMPOSITIONS
DE60109207D1 (de)	2005-04-07	Orale zusammensetzung
EE200100483A (et)	2002-12-16	Põletikuvastaste vahenditena kasutatavad ühendid
DE60135926D1 (de)	2008-11-06	Orale behandlungsvorrichtung
DE60031024D1 (de)	2006-11-16	Fluorkautschukzusammensetzungen
HUP0203204A3 (en)	2004-06-28	Oral dosage forms
IS6686A (is)	2003-01-16	Hýdrógel-drifið lyfjaskömmtunarform
DE60028268D1 (de)	2006-07-06	Fluorkautschukzusammensetzungen
EE200100502A (et)	2002-12-16	Ühendid
DE60007530D1 (de)	2004-02-05	Oral wirksame androgene
ID29149A (id)	2001-08-02	Komposisi adjuvan
DE10196204T1 (de)	2003-04-24	Orale Vorrichtungen
NO20020030D0 (no)	2002-01-04	Krystallinske 1-metylcarbapenemforbindelser
NO20041383L (no)	2004-06-01	Flashsmelte oral doseringsformulering
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
DE60326998D1 (de)	2009-05-14	Orale zubereitung
NO20002439L (no)	2000-05-11	Nye orale doseringsformer for carvediol
ID29533A (id)	2001-09-06	Senyawa-senyawa kalsilitik
ID30397A (id)	2001-11-29	Larutan oral prukaloprida
NO20023190D0 (no)	2002-07-01	Orale mukosale doseringsformer for apomorfin
DK1216032T3 (da)	2008-06-02	Orale formuleringer med kontrolleret frigivelse
NO20030416D0 (no)	2003-01-27	Krystallinsk terapeutisk forbindelse
ES1047845Y (es)	2001-10-01	Alimentador alveolar

Legal Events

Date	Code	Title	Description
2006-06-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application